Atlas Trials

Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients

Clinical trial NCT06225284 · RECRUITING

Trial details

NCT number
NCT06225284
Sponsor
National Taiwan University Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Triple Negative Breast CancerPremenopausal Breast Cancer
Start date
2024-08-22
Primary completion
2026-12-01
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.